1. aMeerpoel, L.; Roevens Peter Walter, M.; Backx Leo Jacobus, J.; Van Der Veken Louis Jozef, E.; Viellevoye, M. Polyarylcarboxamides useful as lipid lowering agents. WO2002020501A1, 2002;
2. bMeerpoel, L.; Backx Leo Jacobus, J.; Jaroskova, L.; Roevens Peter Walter, M.; Van Der Veken Louis Jozef, E.; Viellevoye, M.; Linders Joannes Theodorus, M. MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles. WO2005085226A1, 2005;
3. cBonaventure, P.; Carruthers, N. I.; Chai, W.; Dvorak, C. A.; Jablonowski, J. A.; Rudolph, D. A.; Seierstad, M.; Shah, C. R.; Swanson, D. M.; Wong, V. D. Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor. US20070100141A1, 2007;
4. dAltman, M.; Christopher, M.; Grimm, J. B.; Haidle, A.; Konrad, K.; Lim, J.; Maccoss, R. N.; Machacek, M.; Osimboni, E.; Otte, R. D.; Siu, T.; Spencer, K.; Taoka, B.; Tempest, P.; Wilson, K.; Woo, H. C.; Young, J.; Zabierek, A. Inhibitors of janus kinases. WO2008156726A1, 2008;
5. Design, synthesis and biological evaluation of imidazo[1,5-a]pyridine–PBD conjugates as potential DNA-directed alkylating agents